GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Veedol Corp Ltd (BOM:590005) » Definitions » Other Net Income (Loss)

Veedol (BOM:590005) Other Net Income (Loss) : ₹-0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Veedol Other Net Income (Loss)?

Veedol's Other Net Income (Loss) for the three months ended in Dec. 2024 was ₹-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-0 Mil.

Veedol's quarterly Other Net Income (Loss) stayed the same from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹0 Mil) but then declined from Sep. 2024 (₹0 Mil) to Dec. 2024 (₹-0 Mil).

Veedol's annual Other Net Income (Loss) stayed the same from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹0 Mil) but then declined from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹-0 Mil).


Veedol Other Net Income (Loss) Historical Data

The historical data trend for Veedol's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veedol Other Net Income (Loss) Chart

Veedol Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.40 - - - -

Veedol Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Veedol Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veedol Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Veedol's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Veedol Business Description

Traded in Other Exchanges
Address
8, Dr. Rajendra Prasad Sarani, Yule House, Kolkata, WB, IND, 700001
Veedol Corp Ltd is a manufacturer and marketer of quality lubricants in over 70 countries around the globe. The Veedol range of products includes high-performance engine oils for passenger cars, two/three-wheelers, heavy commercial vehicles, off-highway vehicles, buses and tractors. It also has gear oils, transmission oils, coolants, brake oil and greases for all automotive applications as well as a wide range of industrial and speciality lubricants catering to diverse industry applications. The entire product range offers appropriate choices for various applications and performance levels keeping pace with the latest technical requirements of OEMs.

Veedol Headlines

No Headlines